A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
Hoosier Cancer Research Network
Hoosier Cancer Research Network
National Cancer Institute (NCI)
University of Southern California
AHS Cancer Control Alberta
Eastern Cooperative Oncology Group
University of Pisa
University of Birmingham
University of Miami
Stanford University
Federation Francophone de Cancerologie Digestive
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Assistance Publique - Hôpitaux de Paris